First RNA-Based Blood Test Available for IBS, IBD Diagnoses, IQuity Announces

First RNA-Based Blood Test Available for IBS, IBD Diagnoses, IQuity Announces
IQuity, a leading life science technology company in the field of RNA-based diagnosis, announced the release of IsolateIBS-IBD, a pioneering blood test that helps clinicians identify with great accuracy irritable bowel syndrome (IBS) or inflammatory bowel disease (IBD), allowing patients to receive treatment much faster. The test analyzes a person’s RNA (the intermediate molecule between DNA and protein) retrieved from a small blood sample and identifies with 90% accuracy if someone carries a genetic signature for either IBD or IBS. Because both of these diseases share many symptoms but require unique treatments, a correct diagnosis can be challenging, with patients undergoing a battery of tests
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *